Literature DB >> 34515840

Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degeneration.

Han Joo Cho1, Jaemin Kim2, Seung Kwan Nah2, Jihyun Lee2, Chul Gu Kim2, Jong Woo Kim2.   

Abstract

PURPOSE: To evaluate morphologic changes of choroidal neovascularization (CNV) on optical coherence tomography angiography (OCTA) during the nonexudative period and to correlate the features and timing of recurrence in neovascular age-related macular degeneration. (AMD).
METHODS: Two hundred thirty-eight eyes with type 1 CNV were retrospectively reviewed. For cases with exudative recurrence, OCTA images were tracked for analysis between the recurrences. Qualitative parameters of morphologic changes of CNV on OCTA, including tiny branching vessels, anastomotic loops, peripheral vascular arcade, and perilesional halo, were correlated with the features of exudative recurrence.
RESULTS: Exudative recurrence was identified in 163 cases, and among them, nonexudative morphological changes in CNV were identified using OCTA in 45 cases. For the cases with nonexudative changes on OCTA, exudative recurrence eventually developed within 0.5-3.5 months (mean, 2.3 ± 2.0 months) after identifying morphologic changes OCTA. The following changes in CNV were revealed on OCTA: tiny branching vessels in 53.3% (24/45) of cases, anastomotic loops in 40.0% (18/45), peripheral vascular arcades in 44.4% (20/45), and perilesional halo in 35.6% (16/45). Among the morphologic parameters, development of tiny branching vessels was significantly associated with early exudative recurrence (1.5 ± 1.2 months, p = 0.019), higher incidence of intraretinal fluid (IRF) (p = 0.016), and subretinal or subretinal pigment epithelial hemorrhage (p = 0.023) at recurrence, compared with other morphologic changes.
CONCLUSION: Development of tiny branching vessels of CNV on OCTA during the nonexudative period was associated with early exudative recurrence, including IRF or hemorrhage. Identifying the nonexudative changes of CNV on OCTA might predict exudative recurrence and provide additional parameters for monitoring neovascular AMD.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Age-related macular degeneration; Choroidal neovascularization; Optical coherence tomography angiography; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2021        PMID: 34515840     DOI: 10.1007/s00417-021-05405-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

Review 1.  Age-related macular degeneration.

Authors:  Rama D Jager; William F Mieler; Joan W Miller
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 2.  Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors.

Authors:  Hemal Mehta; Adnan Tufail; Vincent Daien; Aaron Y Lee; Vuong Nguyen; Mehmet Ozturk; Daniel Barthelmes; Mark C Gillies
Journal:  Prog Retin Eye Res       Date:  2018-01-02       Impact factor: 21.198

Review 3.  Optical coherence tomography angiography.

Authors:  Richard F Spaide; James G Fujimoto; Nadia K Waheed; Srinivas R Sadda; Giovanni Staurenghi
Journal:  Prog Retin Eye Res       Date:  2017-12-08       Impact factor: 21.198

4.  Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration.

Authors:  Yali Jia; Steven T Bailey; David J Wilson; Ou Tan; Michael L Klein; Christina J Flaxel; Benjamin Potsaid; Jonathan J Liu; Chen D Lu; Martin F Kraus; James G Fujimoto; David Huang
Journal:  Ophthalmology       Date:  2014-03-27       Impact factor: 12.079

5.  Early OCT angiography changes of type 1 CNV in exudative AMD treated with anti-VEGF.

Authors:  Luisa Frizziero; Anna Rita Daniele; Elisabetta Pilotto; Enrica Convento; Evelyn Longhin; Francesca Guidolin; Raffaele Parrozzani; Fabiano Cavarzeran; Edoardo Midena
Journal:  Br J Ophthalmol       Date:  2018-03-22       Impact factor: 4.638

Review 6.  A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.

Authors:  Ursula Schmidt-Erfurth; Sebastian M Waldstein
Journal:  Prog Retin Eye Res       Date:  2015-08-22       Impact factor: 21.198

7.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

Authors:  Peter K Kaiser; Barbara A Blodi; Howard Shapiro; Nisha R Acharya
Journal:  Ophthalmology       Date:  2007-07-12       Impact factor: 12.079

8.  Optical coherence tomography angiography in exudative age-related macular degeneration: a predictive model for treatment decisions.

Authors:  Florence Coscas; Marco Lupidi; Jean François Boulet; Alexandre Sellam; Diogo Cabral; Rita Serra; Catherine Français; Eric H Souied; Gabriel Coscas
Journal:  Br J Ophthalmol       Date:  2018-11-22       Impact factor: 4.638

9.  Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography.

Authors:  Kunho Bae; Hyo Jung Kim; Yong Kyun Shin; Se Woong Kang
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

10.  UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.

Authors:  Krishnappa C Madhusudhana; Aaron Y Lee; Pearse A Keane; Usha Chakravarthy; Robert L Johnston; Catherine A Egan; Dawn Sim; Javier Zarranz-Ventura; Adnan Tufail; Martin McKibbin
Journal:  Br J Ophthalmol       Date:  2016-03-30       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.